H.C. Wainwright reiterates Crescent Biopharma stock rating at buy
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
If a Market Correction Is Coming, Warren Buffett Says This 1 Move Is Key to Building Wealth
Following Warren Buffett's advice could help investors successfully navigate market volatility.
CME Plans Tungsten Futures as US, Europe Seek Price Stability
CME Group plans to launch tungsten futures early in the first quarter of 2027, creating a derivatives market for the critical mineral as global prices surge.
Euro drops amid high energy prices and street riots in France
Against the yen, the US dollar is up 0.12% at 158.20